Showing 1 - 10 of 5,809
decreasing costs. Pharmaceutical firms in India and China are increasingly forging partnerships with these corporations to gain … intellectual property. Several firms in India and China are performing advanced R&D and are moving into the highest-value segments …
Persistent link: https://www.econbiz.de/10014047447
Related Intellectual Property Rights (TRIPS). We analyze the issue of access to patented medicine to treat global and … this framework to TRIPS. We then propose criteria for assessing the correct balance between the rights of producers and …
Persistent link: https://www.econbiz.de/10014066986
they conceptualise and consecutively propose to solve the problem of providing life-saving pharmaceuticals to the poor in …. However, there are important differences in detail: Pogge identifies the patent protection system as the crucial problem. He … opposes compulsory licensing, which annuls patent protection on a case by case basis, as a pseudo-solution. Instead, he …
Persistent link: https://www.econbiz.de/10011757929
Persistent link: https://www.econbiz.de/10012433673
Persistent link: https://www.econbiz.de/10013545964
Persistent link: https://www.econbiz.de/10014303079
Persistent link: https://www.econbiz.de/10011453911
1. Pharmaceutical industry structure and its effect on marketing performance and product innovation -- 2. The environmental forces that influence industry stakeholders and shape their interactions -- 3. Global health care systems and market access : variations on a theme -- 4. The structure of...
Persistent link: https://www.econbiz.de/10013181948
Randomized Controlled Trials (RCT) data continues to be the gold standard as evident for clinical safety and efficacy. It supports product registration and prescriptions in pharma and healthcare. RCTs provide data in the real-world clinical settings; however, their controlled nature within the...
Persistent link: https://www.econbiz.de/10012981010
Surveillance in Argentina -- Addiction Markets: The Case of High-Dose Buprenorphine in France -- Pharmaceuticals in Urban Ecologies …In some parts of the world spending on pharmaceuticals is astronomical. In others people do not have access to basic or … individuals in relation to global pharmaceuticals. Some essays show how individual and communal identities are affected by the …
Persistent link: https://www.econbiz.de/10014488467